ARTICLE | Financial News

CAR T company Autolus raises $80M series C

September 29, 2017 9:36 PM UTC

On Sept. 26, chimeric antigen receptor (CAR) T cell therapy company Autolus Ltd. (London, U.K.) raised $80 million in a series C round from new investors Cormorant Asset Management and Nextech Invest and existing investors Syncona Ltd., Woodford Investment Management and Arix Bioscience...